research Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
JAK1 gene variation may increase alopecia areata risk.
Search
for
Sort by
Research
30 / 1000+ resultsresearch Finasteride 98319‐26‐7
research Citalopram and finasteride with the lot number FI0510058-A have been voluntarily recalled by Greenstone, after a labelling error
research 198 Dutasteride for men with androgenic alopecia unresponsive to finasteride
research “Finasteride”
research A new mutation Rim3 resembling Re den is mapped close to retinoic acid receptor alpha (Rara) gene on mouse Chromosome 11
research A Prospective Self-controlled Clinical Trial of Nonactivated Low Leukocyte PRP in Female Pattern Hair Loss Patients of Childbearing Age: Erratum
research A Prospective Self-controlled Clinical Trial of Nonactivated Low Leukocyte PRP in Female Pattern Hair Loss Patients of Childbearing Age: Erratum
research Frontal hairline design
The document's conclusion cannot be provided because the content is not accessible.
research Correction to "Safety and Efficacy of REGENDIL Infused Hair Growth Promoting Product in Adult Human Subject Having Hair Fall Complaints (Alopecia)".
research Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.
research Male androgenetic alopecia
The document's conclusion cannot be provided because the content is not available.
research 17beta Hydroxysteroid Dehydrogenase Type 3 Inhibitors
The document's conclusion cannot be provided because the document is not available or cannot be read.
research 004 Post Finasteride Syndrome: is Dutasteride Unfairly Accused?
research Finasteride
research Throwing Caution to the Wind?
The document's conclusion cannot be summarized because the content is not available.
research Solubilization and Solid‐State Characterization of a Poorly Soluble 5‐α Reductase Inhibitor
GI197111X is best dissolved in Capmul MCM for trials.
research Treating patients with female alopecia
The document's conclusion cannot be provided because the document is not available or cannot be parsed.
research Advertiser Beware
The document's conclusion cannot be provided because the document is not readable or understandable.
research A Proposal from Steven C. Chang, MD
The document's conclusion cannot be provided because the document is not readable.
research 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
The document's conclusion cannot be provided because the content is not available.
research Surgical Assistant’s Pearl on Graft Cutting
The document's conclusion cannot be provided because the content is not available to parse.
research [RETRACTED] Restolin Reviews Amazon: UK, USA, Australia, South Africa, Canada, NZ (Ingredients Updates) v1
The document is retracted and cannot be summarized.
research Telogen effluvium acuto
The document's conclusion cannot be determined from the provided text.
research 842Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS)
research Cyberspace Chat: Scalp biopsies: to refer or not to refer?
The conclusion cannot be provided because the document is not accessible.
research NUDT15,FTO, andRUNX1genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.
research Hair Replacement Surgery: Textbook and Atlas
The document's conclusion cannot be provided because the content is not accessible or understandable.
research 396 A novel investigator global assessment score for the evaluation of keratosis pilaris
The document's conclusion cannot be provided because the content is not accessible.
research PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.